Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015

1
Appetite (Eating) Disorders Global Clinical
Trials Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Appetite (Eating) Disorders Global Clinical
  Trials Review, H2, 2015 provides an overview of
  Appetite (Eating) Disorders clinical trials
  scenario. This report provides top line data
  relating to the clinical trials on Appetite
  (Eating) Disorders. Report includes an overview
  of trial numbers and their average enrollment in
  top countries conducted across the globe. The
  report offers coverage of disease clinical trials
  by region, country (G7 E7), phase, trial
  status, end points status and sponsor type.
  Report also provides prominent drugs for
  in-progress trials (based on number of ongoing
  trials).
• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• - Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/appetite
  -eating-disorders-global-clinical-trials-review-h2
  -2015-market

3


Table of Content
Table of Contents 2List of Tables 3List of
Figures 4Report Guidance 5Clinical Trials by
Region 6Clinical Trials and Average Enrollment
by Country 7Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 10Top Five
Countries Contributing to Clinical Trials in
Europe 11Top Countries Contributing to Clinical
Trials in North America 12Top Countries
Contributing to Clinical Trials in Middle East
and Africa 13Top Countries Contributing to
Clinical Trials in Central and South America
14Clinical Trials by G7 Countries Proportion of
Appetite (Eating) Disorders to Central Nervous
System Clinical Trials 15Clinical Trials by
Phase in G7 Countries 16Clinical Trials in G7
Countries by Trial Status 17Clinical Trials by
E7 Countries Proportion of Appetite (Eating)
Disorders to Central Nervous System Clinical
Trials 18Clinical Trials by Phase in E7
Countries 19Clinical Trials in E7 Countries by
Trial Status 20Clinical Trials by Phase 21In
Progress Trials by Phase 22
4


Table of Content
Clinical Trials by Trial Status 23Clinical
Trials by End Point Status 24Subjects Recruited
Over a Period of Time 25Clinical Trials by
Sponsor Type 26Prominent Sponsors 27Top
Companies Participating in Appetite (Eating)
Disorders Therapeutics Clinical Trials
28Prominent Drugs 30Clinical Trial Profile
Snapshots 31Appendix 163Abbreviations
163Definitions 163Research Methodology
164Secondary Research 164About GlobalData
165Contact Us 165Disclaimer 165Source
166 Enquire At http//www.researchbeam.com/app
etite-eating-disorders-global-clinical-trials-revi
ew-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/appetite-eating-disord
ers-global-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com